Government enforcement counsel Katherine Wang co-authored an article for Law360 that examines the potential impact of China’s new three-year anti-commercial bribery campaign intended to specifically target 10 large cities and provinces.
The Feb. 27 article, titled “China Anti-Bribery Rules Raise Questions For Life Sciences” highlights China’s decision to implement a blacklist of individuals and companies in the health care industry that have been subject to bribery-related investigations, penalties or convictions. The article also discusses Nine Prohibitions to Strengthen Ethical Conduct in the Healthcare Industry, as determined by China’s National Health and Family Planning Commission.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.